<DOC>
	<DOCNO>NCT00385632</DOCNO>
	<brief_summary>The purpose study compare effect two different anti-HIV drug regimen quality life health care utilization among SMART study participant .</brief_summary>
	<brief_title>Effects Two Anti-HIV Drug Regimens Quality Life Health Care Use Among SMART Study Participants</brief_title>
	<detailed_description>Advances antiretroviral therapy ( ART ) dramatically reduce mortality morbidity rate HIV infect people . However , HIV infection costly disease treat . With improvement survival , quality life long-term cost HIV treatment become increasingly important majority individual infect HIV . Different HIV treatment regimen may lead variation quality life health care cost course treatment . In SMART study , participant randomly assign one two treatment group : - Group 1 participant follow drug conservation ( DC ) regimen ART stop defer CD4 cell count drop 250 cells/mm3 , initiate CD4 cell count least 350 cells/mm3 , follow episodic ART base CD4 cell count . - Group 2 participant follow viral suppression ( VS ) regimen ART continue keep viral load low possible , regardless CD4 cell count . The purpose study compare DC VS regimens affect quality life , symptom severity , health care utilization , result cost among SMART study participant . At baseline , participant complete questionnaire regard quality life , symptom , health care utilization , current insurance , socioeconomic status . Body appearance sign HIV disease progression also assess time . Follow-up evaluation quality life symptom repeat Months 4 , 8 , 12 annually thereafter . Follow-up evaluation baseline measure occur year .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Coenrollment SMART study Parent guardian willing provide inform consent , applicable</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Treatment Experienced</keyword>
</DOC>